Editorial: a clinical decision tool to identify patients who might benefit most from intensified dosing in the biological era—getting nearer? Authors' reply

Parambir S. Dulai

doi:10.1111/apt.15671

Editorial: a clinical decision tool to identify patients who might benefit most from intensified dosing in the biological era—getting nearer? Authors' reply

Parambir S. Dulai^*

^*Corresponding author for this work

Medicine, Gastroenterology Division

Research output: Contribution to journal › Editorial › peer-review

5 Scopus citations

Original language	English (US)
Pages (from-to)	738-739
Number of pages	2
Journal	Alimentary Pharmacology and Therapeutics
Volume	51
Issue number	7
DOIs	https://doi.org/10.1111/apt.15671
State	Published - Apr 1 2020

ASJC Scopus subject areas

Hepatology
Gastroenterology
Pharmacology (medical)

Access to Document

10.1111/apt.15671

Cite this

@article{514c59cea5ff4b698e1174848982e47f,

title = "Editorial: a clinical decision tool to identify patients who might benefit most from intensified dosing in the biological era—getting nearer? Authors' reply",

author = "Dulai, {Parambir S.}",

year = "2020",

month = apr,

day = "1",

doi = "10.1111/apt.15671",

language = "English (US)",

volume = "51",

pages = "738--739",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "John Wiley and Sons Inc.",

number = "7",

}

TY - JOUR

T1 - Editorial

T2 - a clinical decision tool to identify patients who might benefit most from intensified dosing in the biological era—getting nearer? Authors' reply

AU - Dulai, Parambir S.

PY - 2020/4/1

Y1 - 2020/4/1

UR - http://www.scopus.com/inward/record.url?scp=85081720244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081720244&partnerID=8YFLogxK

U2 - 10.1111/apt.15671

DO - 10.1111/apt.15671

M3 - Editorial

C2 - 32162371

AN - SCOPUS:85081720244

SN - 0269-2813

VL - 51

SP - 738

EP - 739

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

IS - 7

ER -

Editorial: a clinical decision tool to identify patients who might benefit most from intensified dosing in the biological era—getting nearer? Authors' reply

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this